In a clinical setting, the carcinoembryonic antigen (CEA) and carbohydrate antigen 199 (CA199) are commonly used as CRC markers, but they show less sensitivity and reduced specificity for the diagnosis and prognostic assessment of CRC, particularly in patients with early-stage CRC5. Here, CEACAM5 is linked to colorectal carcinoma.